Medtronic reportedly bids for Intersect ENT

Medtronic has approached Intersect ENT Inc., a California maker of drug-delivery tools used to treat chronic sinusitis, about a potential acquisition, Bloomberg reports.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.